2 past transactions

Amyloid Solution

Series C in 2022
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.

SCAI Therapeutics

Series B in 2021
SCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.